Key result
Endomyocardial biopsy successfully diagnosed cardiac involvement in a patient with Churg-Strauss syndrome and confirmed the resolution of inflammation after 1 month of high-dose prednisone.
Why the study?
Is endomyocardial biopsy a safe and useful tool in the diagnosis and monitoring of therapy in patients with Churg-Strauss syndrome cardiac disease?
Case Report (n=1)
Is endomyocardial biopsy a safe and useful tool in the diagnosis and monitoring of therapy in patients with Churg-Strauss syndrome cardiac disease?
Endomyocardial biopsy is a safe and useful tool for diagnosing and monitoring cardiac involvement in Churg-Strauss syndrome.
Answers are grounded in this paper and cite their sources.
May support endomyocardial biopsy for cardiac EGPA diagnosis and response monitoring; leaves open need for prospective validation.
Churg-Strauss syndrome (CSS) is a rare vasculitis characterized by the clinical triad of asthma, peripheral eosinophilia, and systemic vasculitis. Pulmonary symptoms occur commonly, but gastrointestinal, renal, cardiac, and musculoskeletal manifestations may also occur. Disease activity and expression can be variable, and progressive organ failure may occur in the absence of other clinical or biochemical evidence of disease activity. We report the case of a 73-year-old man who presented with signs and symptoms of an acute myocardial infarction, eosinophilia, a pulmonary infiltrate, and recent onset asthma. The cardiac catheterization was normal, but an endomyocardial biopsy specimen revealed eosinophilic myositis, granuloma formation, and small vessel vasculitis. A repeat endomyocardial biopsy 1 month after the initiation of high dose prednisone therapy showed no evidence of inflammation and no significant fibrosis. We suggest that a endomyocardial biopsy is a safe and useful tool in the diagnosis and monitoring of therapy in patients with CSS cardiac disease.
No takes yet. Share an insight, caveat, or question.
Carr et al. (1999) conducted a case report in Churg-Strauss syndrome (n=1). Endomyocardial biopsy and high dose prednisone therapy was evaluated on Evidence of inflammation and fibrosis on repeat biopsy. Endomyocardial biopsy successfully diagnosed cardiac involvement in a patient with Churg-Strauss syndrome and confirmed the resolution of inflammation after 1 month of high-dose prednisone.
Synapse has enriched 10 related papers. Consider them for comparative context: